Related by context. All words. (Click for frequent words.) 68 nomograms 68 multivariate logistic regression 67 Kaplan Meier analysis 67 Kaplan Meier method 66 multivariate Cox 66 conditional logistic regression 65 logistic regression 65 multiple logistic regression 65 logistic regression analysis 65 nonparametric 64 logistic regression models 64 multivariable logistic regression 64 Logistic regression 63 univariate 63 Multiple logistic regression 63 logistic regression model 63 Reynolds Risk Score 63 Poisson regression 63 immunohistochemical 62 multivariate regression analysis 62 immunohistochemical staining 62 multivariable analysis 62 multivariable Cox 62 Solid Tumors RECIST 62 PSADT 62 intraobserver 61 multivariate analyzes 61 MDRD equation 61 Linear regression 61 multivariate regression 61 ROC curves 60 BODE index 60 logistic regression analyzes 60 myocardial viability 60 Response Evaluation Criteria 60 ImmuKnow assay 60 interobserver reliability 60 ultrasonographic 60 pCR 60 Framingham Risk Score 60 MDRD 60 Kruskal Wallis test 60 preoperative staging 60 biochemical recurrence 60 DNA methylation markers 60 FDG PET CT 60 univariate analyzes 60 HOMA IR 60 Kaplan Meier 60 Descriptive statistics 59 neoadjuvant chemotherapy 59 sensitivity specificity 59 Kaplan Meier survival 59 TNM staging 59 multiple linear regression 59 Multivariate analysis 59 FDG PET 59 NMP# assay 59 EUS FNA 59 proportional hazards 59 binary logistic regression 59 Corus CAD 59 prognostic variables 59 generalized linear 59 univariate analysis 59 tumor histology 59 liver biopsies 59 RT PCR assay 59 HER2 expression 59 HIV tropism 58 CIN2 + 58 FDG-PET/CT 58 PROLARIS 58 oncologic outcomes 58 regression analyzes 58 PITX2 58 NIHSS score 58 histopathologic 58 breast carcinoma 58 Multivariate logistic regression 58 clinico pathological 58 F FDG PET 58 prospectively defined 58 Pearson correlation coefficients 58 histopathologic findings 58 apolipoproteins 58 pancreatic adenocarcinoma 58 gene expression profiles 58 histologic diagnosis 58 odds ratios ORs 58 Mantel Haenszel 58 transient elastography 58 estimated GFR 58 mammographic density 58 cystatin C 58 K ras mutations 58 intact parathyroid hormone 58 preoperative PSA 58 PCa 58 bivariate 58 adenoma 58 SLN biopsy 58 prognostic significance 57 sDNA 57 logistic regressions 57 serum PSA 57 KRAS mutation 57 differentiate squamous 57 intima media thickness 57 Oncotype DX Recurrence Score 57 TRUS biopsy 57 prognostic indicator 57 Kaplan Meier curve 57 retrospective cohort 57 carotid artery thickness 57 #F FDG PET 57 Interrater reliability 57 prostate cancer CaP 57 kidney allograft 57 tissue microarray 57 Doppler echocardiography 57 colorectal adenoma 57 ASCUS 57 interobserver 57 radical nephrectomy 57 observational cohort study 57 Histologic 57 histopathologic diagnosis 57 warfarin dosage 57 Univariate 57 HSCT 57 clinically localized prostate 57 immunohistochemical analysis 57 FDG PET imaging 57 axillary dissection 57 Subgroup analysis 57 thyroglobulin 57 endometrial carcinoma 57 histological subtype 57 preoperative MRI 57 chi squared 57 nodal dissection 56 prognostic 56 molecular subtypes 56 transcranial Doppler 56 PITX2 methylation 56 debulking surgery 56 recursive partitioning 56 QRISK 56 PD2i R 56 transvaginal ultrasound 56 histopathologic examination 56 cytologic 56 covariate 56 OncotypeDX 56 regression equations 56 transcriptional profiling 56 ANOVA 56 RECIST Response Evaluation Criteria 56 hierarchical clustering 56 transesophageal echocardiography 56 microsatellite instability 56 transabdominal 56 acetabular fractures 56 EBUS FNA 56 cDNA microarray 56 preoperative diagnosis 56 Recurrence Score 56 TOP2A 56 adenoma recurrence 56 hepatectomy 56 urodynamic 56 stratifying patients 56 radical prostatectomy RP 56 PSA velocity 56 prospectively randomized 56 Bonferroni 56 perfusion CT 56 PSA nadir 56 BI RADS 56 lipoprotein levels 56 Multiple linear regression 56 gene amplification 56 urine cytology 56 lymphadenectomy 56 response pCR 56 VKORC1 56 clinicopathological 56 Doppler sonography 56 ImmuKnow 56 HGPIN 56 MetS 56 fetal echocardiography 56 cDNA libraries 56 sentinel lymph node biopsy 56 meta regression 56 contralateral breast 56 bisulfite sequencing 56 atypical hyperplasia 56 Fractional Flow Reserve 56 chromosomal mutations 55 radioimmunoassay 55 Kaplan Meier curves 55 plain radiographs 55 Haptoglobin 55 ultrasound elastography 55 biventricular repair 55 #F FDG 55 confidence intervals CIs 55 Cardiorespiratory fitness 55 histologic subtype 55 LV dysfunction 55 MMSE score 55 miRview ™ squamous 55 predictive validity 55 eplerenone 55 noninferiority 55 linear regressions 55 clinicopathologic 55 radical retropubic prostatectomy 55 elevated CRP 55 transvaginal sonography 55 metabolite concentrations 55 allele frequencies 55 Glomerular filtration rate 55 nephron sparing surgery 55 Angiographic 55 stepwise logistic regression 55 thickness CIMT 55 Pearson correlation coefficient 55 renal tumors 55 fine needle aspiration 55 endometrial biopsy 55 prognostic factors 55 guaiac 55 xCELLigence System 55 MTT assay 55 PSA kinetics 55 prognostic marker 55 Sentinel Lymph Node Biopsy 55 COR Analyzer 55 ROC curve 55 deCODE BreastCancer TM 55 radiochemotherapy 55 SYNTAX Score 55 troponins 55 HNSCC 55 EuroSCORE 55 prognostic biomarker 55 multicentre randomized 55 lymph node metastasis 55 Multivariate 55 resected pancreatic cancer 55 pretargeting 55 multislice 55 pretest probability 55 polygonal method 55 metaplasia 55 advanced neoplasia 55 angiographically 55 Liver biopsy 55 chest radiographs 55 carotid stenosis 55 genotypic resistance 55 dimensional echocardiography 55 morphometric vertebral fractures 55 hemoglobin A1c levels 55 immunochemical fecal occult 55 chemoradiotherapy 55 Bayesian analysis 55 Lp PLA2 55 nodal metastasis 55 etiologic 55 coronary calcification 55 quantitative gene expression 55 inhibin B 55 coronary stenosis 55 eGFR 55 Wilcoxon rank sum 55 postoperative complication 55 MR spectroscopy 55 prognostic markers 55 PCA3 55 RT qPCR 55 prognostic indicators 55 generalized estimating 55 PCR assay 55 hepatic resection 54 advanced adenomas 54 telomere lengths 54 platelet reactivity 54 liver transplant recipients 54 prostate biopsy 54 liver biopsy 54 Coronary artery calcium 54 neoadjuvant therapy 54 genomewide 54 transrectal ultrasound guided 54 N glycan 54 NMP# 54 TAXUS Express Stent 54 FRAX 54 FDG PET scans 54 familial aggregation 54 noninvasive technique 54 B7 H3 54 IL#B 54 serum biomarkers 54 leukocyte count 54 co receptor tropism 54 inhibin 54 Getzenberg 54 SYNTAX 54 GSTP1 54 transrectal ultrasound 54 haplotype map 54 renal cell carcinomas 54 CC genotype 54 adjuvant therapies 54 NSTE ACS 54 covariance ANCOVA 54 carotid IMT 54 transcranial Doppler ultrasound 54 microalbuminuria 54 tPSA 54 urothelial carcinoma 54 sipuleucel T 54 creatinine clearance 54 subclinical atherosclerosis 54 microarray analysis 54 Randomized clinical trials 54 ELISpot 54 multivariable regression 54 arterial thickening 54 definite stent thrombosis 54 Immunohistochemistry 54 axillary lymph nodes 54 SUVmax 54 AtherOx 54 adjuvant therapy 54 multiplex PCR 54 morphometric 54 D dimer 54 randomized controlled trials RCTs 54 variance ANOVA 54 electron beam computed tomography 54 symptomatic VTE 54 DNA methylation patterns 54 APTIMA HPV 54 SYNTAX trial 54 Annexin V 54 Cytogenetic 54 Flow cytometry 54 Lymph node 54 KRAS mutations occur 54 GeneSearch 54 spectrophotometric 54 hip resurfacing arthroplasty 54 cytological 54 Framingham Offspring Study 54 prospective longitudinal 54 prostate carcinoma 54 sonographic findings 54 interrater reliability 54 histologically 54 retrospective cohort study 54 flow cytometric 54 MiCK assay 54 EBMT criteria 54 GAMMAGARD 54 hyperintense lesions 54 gastric adenocarcinoma 54 locoregional recurrence 54 microsimulation model 54 metabolomic profiles 54 Fine Needle Aspiration 54 percutaneous biopsy 54 acetabular fracture 54 biopsied tissue 54 karyotype 54 Finite element 54 gated SPECT 54 #.#ng/ml 54 MitraClip device 54 Histopathologic 54 albumin excretion 54 pairwise comparisons 54 Bayesian inference 54 SLNB 54 colon capsule endoscopy 54 radiographic outcomes 54 covariance 54 Logistic regression analysis 54 epithelial ovarian cancer 54 nonfasting triglyceride levels 54 retrospectively analyzed 54 surrogate endpoint 54 proteomic analysis 54 gadolinium enhanced 54 liver metastasis 54 underwent radical prostatectomy 54 exhaled nitric oxide 54 correlational 54 echocardiographic 54 retest reliability 54 GnRH agonists 54 molecular markers 54 convergent validity 54 echocardiographic parameters 54 sirolimus stent 54 transthoracic 54 anthropometric measurements 54 gene expression patterns 54 cystatin 54 micrometastasis 54 virologic response 53 RRM1 53 genotypic 53 RECIST 53 mineral density BMD 53 linear regression analysis 53 sonographically guided 53 endorectal coil 53 Oncotype 53 LDL HDL 53 Carotid Revascularization Endarterectomy vs. 53 mL/min/#.# m 2 53 pharmacodynamic effects 53 leiomyomas 53 urolithiasis 53 axillary node dissection 53 molecular biomarker 53 antibody titer 53 PLCO 53 NOD mouse 53 perioperative mortality 53 penetrance 53 Affymetrix arrays 53 VerifyNow P#Y# 53 postoperative chemotherapy 53 microRNA expression 53 endometrial thickness 53 SpyGlass System 53 ductal cancer 53 Her2/neu 53 fluorodeoxyglucose positron emission tomography 53 hormone receptor status 53 histologic 53 axillary lymph node dissection 53 Cervista HPV HR 53 SPECT MPI 53 gauge vitrectomy 53 Multivariable 53 OPCAB 53 histopathological 53 glomerular filtration rate 53 endoglin 53 racemic baclofen 53 prognostic factor 53 CHADS2 53 advanced adenoma 53 randomizing patients 53 prostate cancer PCa 53 endometrial hyperplasia 53 thrombophilia 53 sentinel lymph node 53 CR nPR 53 retrospective observational study 53 nonsmall cell lung cancer 53 CALGB 53 coronary calcium 53 lognormal 53 array CGH 53 BMI percentile 53 baseline LDH 53 FCGR3A 53 Regression analysis 53 lipid lowering therapy 53 precursor lesions 53 coronary CTA 53 scintigraphic 53 colonoscopic 53 dose Iluvien 53 Non inferiority 53 ischemic cardiomyopathy 53 CORE OM 53 PD2i ® 53 abnormal cytology 53 ROCKET AF 53 adnexal mass 53 cystectomy 53 NAMCS 53 MammaPrint R 53 CT coronary angiography 53 seminal vesicle invasion 53 standard chemotherapy regimen 53 operable breast cancer 53 NSABP B 53 postoperative mortality 53 EBRT 53 biochemical relapse 53 RNA seq 53 FDG uptake 53 sentinel node biopsy 53 varicoceles 53 Multivariable logistic regression 53 nondiabetic patients 53 DEXA scan 53 external beam radiotherapy 53 cardiac perfusion 53 RE LY ® 53 helical CT 53 genomewide association studies 53 immunostaining 53 estrogen receptor ER 53 CaPSURE 53 florbetaben 53 DMIST 53 radical prostatectomy 53 biomarker 53 chemoprevention trials 53 posttransplant 53 oncological outcomes 53 Prostate Specific Antigen PSA 53 rFSH 53 semiquantitative 53 coronary angiography 53 anthropometric measures 53 adenomatous 53 fFN 53 multivariable 53 hsCRP levels 53 subgroup analyzes 53 Regression analyzes 53 Sanger sequencing 53 thyrotropin levels 53 NIHSS 53 PCI ExTRACT TIMI 53 intraclass correlation coefficients 53 inferential statistics 53 metaanalysis 53 invasive lobular 53 Lp PLA 2 53 covariates 53 LVNC 53 p# biomarker 53 microsatellite markers 53 XIENCE V PROMUS Stent 53 ratio WHR 53 surrogate markers 53 differential gene expression 53 bronchopulmonary dysplasia BPD 53 postmenopausal hormone 53 nephrectomy 53 DNA methylation biomarker 53 DEXA 53 conventional coronary angiography 53 lung metastasis 53 histological subtypes 53 Histological 53 APOE genotype 53 MGUS 53 adjuvant systemic 53 metabolomic profiling 53 HERmark 53 fetuin 53 microarray experiments 53 histological 53 Fontan procedure 53 stratify patients 53 procalcitonin 53 immunohistochemistry 53 gallstone disease 53 femoral neck BMD 53 genes CYP#C# 53 adolescent idiopathic scoliosis 53 hemodialysis patients 53 invasive lobular carcinoma 53 dyssynchrony 53 Estrogen Receptor 53 secondary efficacy endpoint 53 transcriptomic 53 cTnI 53 unpaired t 53 monozygotic twins 53 NGAL 53 MSCT 53 hematopoietic cancers 53 pelvic ultrasound 53 null hypothesis 53 preoperatively 53 CARDIA 53 vertebral fracture 53 specific antigen PSA 53 Genotypic 53 biopsy Gleason 53 perioperative morbidity 53 tamoxifen therapy 53 Hemoccult II 53 multivariable adjusted 53 invasive ductal 53 magnetic resonance spectroscopy MRS 53 quantitative RT PCR 53 methylation patterns 52 malignant lesions 52 estimated glomerular filtration 52 IPAH 52 risk stratification 52 μmol L 52 serum creatinine levels 52 ECLS 52 FFR guided treatment 52 electrophysiologic 52 carotid intima media 52 obstructive coronary artery 52 rs# [001] 52 death reinfarction 52 neoadjuvant 52 pT2 52 thickness IMT 52 albumin creatinine ratio 52 UKPDS 52 T1a 52 myocardial infarct size 52 Leydig cell 52 everolimus eluting stents 52 microalbumin 52 κ 52 Sensitivity analyzes 52 ARB telmisartan 52 regression coefficients 52 preoperative chemotherapy 52 pertuzumab 52 ADPKD 52 SSc 52 T2 lesions 52 CYP#D# genotype 52 autosomal 52 PIB PET 52 colonic polyps 52 pelvic lymphadenectomy 52 hepatic fibrosis 52 carotid artery intima media 52 eosinophil count 52 adjuvant chemotherapy 52 osteopenic 52 longitudinal cohort study 52 angiography CCTA 52 genetic polymorphisms 52 oral glucose tolerance 52 variant rs# 52 Affymetrix microarray technology 52 situ hybridization 52 putative biomarkers 52 graft occlusion 52 Index CDAI 52 fibroadenomas 52 breast cancer subtypes 52 subanalysis 52 radioiodine therapy 52 underwent surgical resection 52 serum creatinine 52 colorectal liver metastases 52 posttest 52 XELOX 52 LungExpress Dx 52 PD2i 52 core needle biopsy 52 liver histology 52 cerebral oximetry 52 differentially expressed genes 52 ABL1 52 radiation dosimetry 52 macroalbuminuria 52 Univariate analysis 52 phylogenetic analyzes 52 distant metastases 52 linear regression analyzes 52 diffusion tensor 52 N. Engl 52 waist circumference WC 52 tumor recurrence 52 PAM# [001] 52 epithelial tumors 52 RQ PCR 52 estrogen progestin therapy 52 nipple aspirate fluid 52 peak VO2 52 thyroid nodules 52 SpHb 52 PD2i algorithm 52 TMPRSS2 ERG fusion 52 Bonferroni correction 52 diagnostic modality 52 #Gy 52 myocardial perfusion 52 linear regression 52 intraclass correlation coefficient 52 cCTA 52 spiral computed tomography 52 rs# [002] 52 pretransplant 52 Supplementary Table 52 ERCC1 52 eNO 52 diagnostic biomarker 52 VITAL Trial 52 olaparib 52 oligonucleotide microarrays 52 situ LCIS 52 multivariate 52 MADIT CRT trial 52 allelic 52 eTag assays 52 QTL mapping 52 CellSearch ™ 52 galiximab 52 Meta analyzes 52 immunosuppressive regimen 52 antitumor effect 52 cardiac magnetic resonance 52 leiomyoma 52 FGFR2 gene 52 Hb A1C 52 curative resection 52 cardiac troponin 52 microvessel 52 statistical significance p 52 body fatness 52 contrast echocardiography 52 computational algorithms 52 cDNA library 52 IDH1 mutation 52 MDCT 52 heterozygotes 52 efficacy evaluable 52 tumor excision 52 CIMZIA ™ 52 meta analysis 52 Preoperative 52 lactate dehydrogenase 52 catheter angiography 52 induced sputum 52 pegylated liposomal doxorubicin 52 multicenter study 52 β blockers 52 transgene expression 52 mammographic 52 mucinous 52 SNP rs# [002] 52 mediastinoscopy 52 dosimetric 52 atypia 52 tHcy 52 PreDx DRS 52 HER2 overexpression 52 prepubertal 52 coronary artery calcium 52 STRIDE PD 52 urologic surgeons 52 noninvasive imaging 52 multigene expression test 52 MELD score 52 differentially expressed proteins 52 relapsed MM 52 APOC3 52 esophageal squamous cell carcinoma 52 alanine aminotransferase ALT 52 multivariable analyzes 52 Third Eye Retroscope 52 atherosclerotic lesion 52 periprocedural MI 52 ovariectomized 52 immunohistochemistry IHC 52 bone scintigraphy 52 immunofluorescent 52 angiographic restenosis 52 pulmonary metastases 52 HLA G 52 computed tomography CT scan 52 miRview TM mets 52 LDL particle 52 BRCA2 mutation carriers 52 transgenic mouse models 52 cerebral microbleeds 52 ChIP chip 52 χ 52 endoscopic ultrasound 52 peritoneal carcinomatosis 52 NMIBC 52 complete cytogenetic response 52 Histopathological 52 conventional cytology 52 chemoembolization 52 FullTerm 52 lateral radiographs 52 sustained virological response 52 radical cystectomy 52 miRview mets 52 multidetector CT 52 hsCRP 52 glomerular 52 ExTRACT TIMI 52 EQ 5D 52 androgen ablation 52 micrometastases 52 foveal thickness 52 Kruskal Wallis 52 vitro experiments 52 rs# [004] 52 hamartoma 52 quantitative PCR 52 adenoma detection 52 hypogonadal 52 nonoperative 51 FDG PET scan 51 AGTR1 51 miRview squamous 51 quantile 51 ertapenem 51 LightTouch 51 HER2 amplification 51 SCr 51 NHANES III 51 gemcitabine carboplatin 51 CCyR 51 interrater 51 prospective multicentre 51 Dr. Victor Velculescu 51 QTc 51 siRNA knockdown 51 T2D 51 APACHE II 51 #S rRNA 51 warfarin dose 51 Sprague Dawley rats 51 transcatheter closure 51 doxorubicin docetaxel 51 TIMP 1 51 node metastases 51 MGd 51 Radical prostatectomy 51 ECG gated 51 HoLEP 51 undergone radical prostatectomy 51 NAFLD 51 metabolic parameters 51 Prognostic Value 51 hepatic lesions 51 nonrandomized studies 51 CIN3 51 Prognostic 51 factorial 51 arterial elasticity 51 histological diagnosis 51 ependymoma 51 NATRECOR ® 51 TRUS 51 thrombus aspiration 51 ACC AHA 51 prostatic adenocarcinoma 51 microdebrider 51 immunosuppressive regimens 51 thyroid carcinoma 51 hip BMD 51 prospective multicenter randomized 51 RhD 51 locoregional 51 anogenital distance 51 Inhibin B 51 voxel 51 antidiabetic medication 51 Heritability 51 sirolimus eluting stents 51 ADRB2 51 Immunohistochemical staining 51 allostatic load 51 lipid abnormalities 51 % CI #.#-#.# [003] 51 BMD measurements 51 arteriography 51 extracapsular extension 51 RECIST criteria 51 median PFS 51 trastuzumab Herceptin ® 51 virologic responses 51 VIAdel TM technology 51 T2DM 51 regression coefficient 51 NNT = 51 MDCT angiography 51 morphologic 51 NT proBNP 51 bladder carcinoma 51 Immunohistochemical analysis 51 metachronous 51 multivariate adjusted 51 malignant nodules 51 postmenopausal hormones 51 RE LY 51 stratifying 51 quantitate 51 folate supplementation 51 serum ferritin 51 Adjuvant therapy 51 genotyping assay 51 SmartChip System 51 idraparinux 51 proteomic biomarkers 51 glycoprotein IIb IIIa inhibitors 51 APOL1 51 lipid profiles 51 gene expression profiling 51 teratoma 51 explanatory variables 51 serum testosterone 51 Computed tomography 51 gene polymorphisms 51 Masimo PVI 51 meta analyzes 51 SerDes transceivers 51 fraternal twin pairs 51 antigen PSA 51 umbilical artery 51 genetic markers 51 QPCR 51 thromboembolic disease 51 paricalcitol 51 osteoid 51 excisional biopsy 51 nonoperative treatment 51 surgical biopsy 51 massively parallel sequencing 51 prognostically 51 serum concentrations 51 lobular breast cancer 51 PSMA ADC 51 undergoing coronary angiography 51 MSH2 51 nonalcoholic steatohepatitis NASH 51 Framingham Offspring 51 plasma pharmacokinetics 51 chemosensitivity 51 aortic stiffness 51 ALND 51 mutated K ras 51 glycated hemoglobin 51 coronary angiogram 51 stereotactic radiotherapy 51 KRAS status 51 Hurthle cell 51 multivariate analysis 51 IKDC 51 HBeAg negative 51 AST ALT 51 Ovu Trac ® 51 Sipuleucel T 51 transaminase levels 51 adenotonsillectomy 51 remission CR 51 T#I [002] 51 DAS# CRP 51 Intermountain Risk Score 51 prostate cancer CRPC 51 parous 51 FeNO 51 SELDI TOF MS 51 transcriptional profiles 51 PCWP 51 multiplexing capability 51 lymph node involvement 51 randomized blinded 51 bivariate analysis 51 comparative genomic hybridization 51 skin sterol 51 LHRH receptor positive 51 colorectal neoplasia 51 proteomes 51 undergoing bariatric surgery 51 CaP 51 genomic profiling 51 bi ventricular pacing 51 pharmacokinetic characteristics 51 ACI TIPI 51 nonvertebral fractures 51 Charlson Comorbidity Index 51 serum GGT 51 TKAs 51 carcinoembryonic antigen 51 liver fibrosis 51 CHAMPION PCI 51 hydroxyvitamin D levels 51 clinicopathological features 51 CARE HF 51 multimodality therapy 51 variant allele 51 IMPT 51 Optical Coherence Tomography 51 cTnT levels